CTLA4 and sarcoidosis: As a result, the adaptive immune response in sarcoidosis and metastasis patients maintains sarcoidosis-related inflammation because of decreased anti-inflammatory CTLA-4 expression while restricting tumor-specific T-cell activation, indicated by an increased PD-1 expression, which enables tumor escape from the immune system and metastasis [35-36].